October 7, 2024
A 1-year course of methotrexate (MTX) in clinically suspected arthralgia may prevent the development of rheumatoid arthritis (RA) in at-risk individuals who test negative for anti-citrullinated […]
October 7, 2024
TOPLINE: A higher rate of weight loss within 1 year of initiating orlistat is associated with lower risks for incident gout and recurrent gout flares in […]
October 7, 2024
TOPLINE: Older adults with antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis face a higher risk for end-stage renal disease or mortality and severe infections. However, frailty, more than […]
October 4, 2024
TOPLINE: Patients with inflammatory rheumatic diseases who are systematically screened for common chronic and preventable diseases are more likely to receive preventive medications and less likely […]
October 1, 2024
The US Food and Drug Administration has approved ustekinumab-aauz (Otulfi), a biosimilar that references Johnson & Johnson’s ustekinumab (Stelara). This is the fourth ustekinumab biosimilar approved […]
September 30, 2024
A noninvasive eye test could help people with Sjögren disease — a disorder that can go undiagnosed for years — get relief sooner, suggested a pilot […]
September 27, 2024
When Jennifer Welsh, a 40-year-old from New Britain, Connecticut, visited her doctor about pain in her joints and neck, her doctor sent her to the emergency […]
September 26, 2024
TOPLINE: Older age, male sex, and seropositivity are linked to a higher risk for rheumatoid arthritis– interstitial lung disease (RA-ILD) with a usual interstitial pneumonia (UIP) […]
September 26, 2024
TOPLINE: Emapalumab (Gamifant)-containing regimens stabilize key laboratory parameters and show a high 12-month survival probability in patients with rheumatologic disease–associated hemophagocytic lymphohistiocytosis (HLH). METHODOLOGY: Researchers conducted […]